Chundao Yang

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Medshine Discovery Inc., Wuxi Biocity Biopharmaceutics Co., Ltd.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chundao Yang. Retrieved from https://idiyas.com/inventor/chundao-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

7 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 72

Medshine Discovery Inc.

patents

3 out of 5

Wuxi Biocity Biopharmaceutics Co., Ltd.

patents

4. 2 out of 5

Shijiazhuang Sagacity New Drug Development Company, Ltd.

patents

5. 1 out of 2

Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory

patents

6. 1 out of 1

Jumbo Drug Bank Co., Ltd.

patent

7. 1 out of 55

Merck Sharp + Dohme B.v.

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Wee1 Inhibitor

BTK Inhibitors

PDE4 Inhibitor

Heterocyclic Compound

Macrocyclic Compound

Pyrimidopyrazolone Derivative

Quinolino-pyrrolidin-2-one

Substituted Benzamides

1H-pyrrolo[2,3-c]pyridine

Cyclic Compound

Tertiary Alcohol Imidazopyrazine

Diaza-benzofluoranthrene

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552789 - 1H-pyrrolo[2,3-c]pyridine compounds and application thereof (2026-02-17),

2. 12291536 - Crystal form of Wee1 inhibitor compound and use thereof (2025-05-06),

3. 12180184 - Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof (2024-12-31),

4. 11613545 - Macrocyclic compound serving as Wee1 inhibitor and applications thereof (2023-03-28),

5. 11384065 - Heterocyclic compound as CSF-1R inhibitor and use thereof (2022-07-12),

6. 11299475 - Prostacyclin receptor agonist (2022-04-12),

7. 11230549 - Quinolino-pyrrolidin-2-one derivative and application thereof (2022-01-25),

8. 10954253 - 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor (2021-03-23),

9. 10662189 - PDE4 inhibitor (2020-05-26),

10. 10532986 - Cyclic compound acting as PDE4 inhibitor (2020-01-14),

11. 10214546 - Btk inhibitors (2019-02-26),

12. 10208047 - Tertiary alcohol imidazopyrazine BTK inhibitors (2019-02-19),

13. 10130630 - BTK inhibitors (2018-11-20),

14. 10087188 - Benzamide imidazopyrazine Btk inhibitors (2018-10-02),

15. 10017507 - Diaza-benzofluoranthrene compounds (2018-07-10),

Title: Chundao Yang - Pioneering Inventor from Shanghai

Introduction: Chundao Yang is a distinguished inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Chundao Yang holds several patents in the areas of artificial intelligence, robotics, and renewable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Chundao Yang has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries.

Collaborations: Throughout his career, Chundao Yang has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Chundao Yang's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his reputation as a trailblazing inventor in the global innovation landscape.

Profile summary based on public USPTO records.